Skip to main content
. 2022 Feb 23;8(1):e12268. doi: 10.1002/trc2.12268

FIGURE 1.

FIGURE 1

Time to dementia with GLP‐1 RAs versus placebo in pooled RCTs. In the pooled RCTs, 15 patients randomized to a GLP‐1 RA and 32 patients randomized to placebo developed dementia. GLP‐1 RA, glucagon‐like peptide‐1 receptor agonist; RCT, randomized controlled trial